EarningsQ1 2023 Earnings Report

Nektar Therapeutics (NKTR) Q1 2023 Earnings Report

0 Followers

MX:NKTR Q1 2023 EPS Results

Actual EPS-$198.88

Consensus EPS-$67.58

Beat/MissMissed by -$131.30

One Year Ago EPS-$133.49

Actual Revenue$392.20M

Expected Revenue$352.53M

Beat/MissBeat by +$39.67M

YoY Revenue Growth-13.00%

QuarterQ1 2023

Date05/09/2023

TimeAfter Close

Conference CallTuesday, May 9, 2023

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NKTR Q1 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-37.72 / -	-33.964	―
Aug 13, 2026	2026 (Q2)	-35.80 / -22.34	-53.579	58.31% (+31.24)
May 07, 2026	2026 (Q1)	-28.73 / -33.06	-65.384	49.44% (+32.33)
Mar 12, 2026	2025 (Q4)	-44.93 / -32.33	8.173	-495.56% (-40.50)
Nov 06, 2025	2025 (Q3)	-48.77 / -33.96	-49.038	30.74% (+15.07)
Aug 07, 2025	2025 (Q2)	-55.00 / -53.58	-68.109	21.33% (+14.53)
May 08, 2025	2025 (Q1)	-46.57 / -65.38	-51.763	-26.32% (-13.62)
Mar 12, 2025	2024 (Q4)	-36.94 / 8.17	-59.936	113.64% (+68.11)
Nov 07, 2024	2024 (Q3)	-54.21 / -49.04	-65.384	25.00% (+16.35)
Aug 08, 2024	2024 (Q2)	-50.40 / -68.11	-73.557	7.41% (+5.45)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed